HomeCompareOCA vs ABBV

OCA vs ABBV: Dividend Comparison 2026

OCA yields 20.01% · ABBV yields 3.67%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OCA wins by $33.2K in total portfolio value
10 years
OCA
OCA
● Live price
20.01%
Share price
$10.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$73.1K
Annual income
$6,746.16
Full OCA calculator →
ABBV
AbbVie Inc.
● Live price
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →

Portfolio growth — OCA vs ABBV

📍 OCA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOCAABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OCA + ABBV cover 4 of 12 monthsgood coverage

Jan
ABBV
Feb
Mar
Apr
ABBV
May
Jun
Jul
ABBV
Aug
Sep
Oct
ABBV
Nov
Dec
OCA pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OCA
Annual income on $10K today (after 15% tax)
$1,700.85/yr
After 10yr DRIP, annual income (after tax)
$5,734.24/yr
ABBV
Annual income on $10K today (after 15% tax)
$312.02/yr
After 10yr DRIP, annual income (after tax)
$981.27/yr
At 15% tax rate, OCA beats the other by $4,752.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OCA + ABBV for your $10,000?

OCA: 50%ABBV: 50%
100% ABBV50/50100% OCA
Portfolio after 10yr
$56.5K
Annual income
$3,950.30/yr
Blended yield
6.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

OCA
No analyst data
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+51.7% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OCA buys
0
ABBV buys
0
No recent congressional trades found for OCA or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOCAABBV
Forward yield20.01%3.67%
Annual dividend / share$2.00$6.20
Payout ratio50%58%
1-year div growth0%4.7%
5-year div CAGR0%8.9%
Portfolio after 10y$73.1K$39.9K
Annual income after 10y$6,746.16$1,154.43
Total dividends collected$41.6K$7.2K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OCA vs ABBV ($10,000, DRIP)

YearOCA PortfolioOCA Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$12,701$2,001.00$11,520$399.75+$1.2KOCA
2$15,965$2,375.21$13,261$450.98+$2.7KOCA
3$19,873$2,790.33$15,255$508.41+$4.6KOCA
4$24,510$3,246.11$17,536$572.74+$7.0KOCA
5$29,968$3,741.65$20,145$644.78+$9.8KOCA
6$36,341$4,275.46$23,126$725.38+$13.2KOCA
7$43,730$4,845.53$26,532$815.52+$17.2KOCA
8$52,241$5,449.34$30,420$916.26+$21.8KOCA
9$61,982$6,083.97$34,855$1,028.80+$27.1KOCA
10$73,067$6,746.16$39,914$1,154.43+$33.2KOCA

OCA vs ABBV: Complete Analysis 2026

OCAStock

Omnichannel Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company intends to focus on 'omnichannel' businesses, such as technology-enabled cross-channel retail and consumer services, including the direct-to-consumer/e-commerce retail, consumer healthcare, consumer marketplaces, consumer services, and related sectors. Omnichannel Acquisition Corp. was incorporated in 2020 and is based in Millburn, New Jersey.

Full OCA Calculator →

ABBVHealthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →
📬

Get this OCA vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OCA vs SCHDOCA vs JEPIOCA vs OOCA vs KOOCA vs MAINOCA vs JNJOCA vs MRKOCA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.